IMMUNITYBIO INC (IBRX) Stock Income Statement
NASDAQ:IBRX - Nasdaq - US45256X1037 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 31.22M | 14.74M | 622.00K | 240.00K | 930.00K | |||
| Minority Interest Expense | 80.00K | 81.00K | 656.00K | 750.00K | 3.06M | |||
| Cost Of Goods | N/A | 0.00 | N/A | N/A | N/A | |||
| Gross Profit | N/A | 14.74M | N/A | N/A | N/A | |||
| Operating Expenses | 344.58M | 358.93M | 361.99M | 350.86M | 331.21M | |||
| Research and Development | 183.03M | 187.14M | 229.47M | 245.45M | 195.36M | |||
| Selling, General, and Administrative Expenses | 159.55M | 169.78M | 130.52M | 103.51M | 135.86M | |||
| Operating Income | -313.42M | -344.18M | -361.36M | -350.62M | -330.28M | |||
| Interest Income/Expense | -121.26M | -95.65M | -173.66M | -63.77M | -19.26M | |||
| Other Income/Expense | 25.26M | 26.19M | -47.98M | -2.22M | -300.00K | |||
| Non Recurring Items | N/A | 0.00 | -886.00K | -680.00K | 0.00 | |||
| Income Before Taxes | -409.42M | -413.64M | -583.89M | -417.29M | -349.84M | |||
| Income Tax | N/A | 0.00 | -40.00K | 30.00K | 10.00K | |||
| Net Income | -409.10M | -413.56M | -583.20M | -416.57M | -346.79M | |||
| EBITDA | -296.59M | -326.63M | -342.85M | -332.36M | -316.04M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.55 | -0.59 | -1.15 | -1.04 | -0.89 | |||
| Non GAAP EPS | -0.56 | -0.61 | -1.13 | -1.05 | -0.89 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | 100.00% | N/A | N/A | N/A | |||
| Profit Margin | -1310.30% | -2804.77% | -93761.41% | -173570.83% | -37289.25% | |||
| Operating Profit Margin | -1003.83% | -2334.23% | -58097.11% | -146091.67% | -35513.98% | |||
All data in USD